Report Detail
Global Drugs for PNH Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4735975 |
- 24 August, 2026 |
- Global |
- 91 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Drugs for PNH market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Drugs for paroxysmal nocturnal hemoglobinuria (PNH) primarily include complement inhibitors that block the destruction of red blood cells. The most common drugs are Eculizumab and Ravulizumab, both of which target complement protein C5 to prevent the formation of the membrane attack complex (MAC), reducing hemolysis, thrombosis risk, and other PNH complications. These drugs are typically administered via intravenous infusion and have significantly improved outcomes for PNH patients.
This report is a detailed and comprehensive analysis for global Drugs for PNH market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drugs for PNH market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drugs for PNH market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drugs for PNH market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drugs for PNH market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs for PNH
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs for PNH market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Alexion Pharmaceuticals, Roche, Apellis Pharmaceuticals, Amgen, Samsung Bioepis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drugs for PNH market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Complement Inhibitors
Others
Market segment by Application
Hospital
Clinic
Other
Major players covered
Novartis
Alexion Pharmaceuticals
Roche
Apellis Pharmaceuticals
Amgen
Samsung Bioepis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for PNH product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drugs for PNH, with price, sales quantity, revenue, and global market share of Drugs for PNH from 2021 to 2026.
Chapter 3, the Drugs for PNH competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for PNH breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drugs for PNH market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drugs for PNH.
Chapter 14 and 15, to describe Drugs for PNH sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Drugs for PNH Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Complement Inhibitors
- 1.3.3 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Drugs for PNH Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Drugs for PNH Market Size & Forecast
- 1.5.1 Global Drugs for PNH Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Drugs for PNH Sales Quantity (2021-2032)
- 1.5.3 Global Drugs for PNH Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Novartis
- 2.1.1 Novartis Details
- 2.1.2 Novartis Major Business
- 2.1.3 Novartis Drugs for PNH Product and Services
- 2.1.4 Novartis Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Novartis Recent Developments/Updates
- 2.2 Alexion Pharmaceuticals
- 2.2.1 Alexion Pharmaceuticals Details
- 2.2.2 Alexion Pharmaceuticals Major Business
- 2.2.3 Alexion Pharmaceuticals Drugs for PNH Product and Services
- 2.2.4 Alexion Pharmaceuticals Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Alexion Pharmaceuticals Recent Developments/Updates
- 2.3 Roche
- 2.3.1 Roche Details
- 2.3.2 Roche Major Business
- 2.3.3 Roche Drugs for PNH Product and Services
- 2.3.4 Roche Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Roche Recent Developments/Updates
- 2.4 Apellis Pharmaceuticals
- 2.4.1 Apellis Pharmaceuticals Details
- 2.4.2 Apellis Pharmaceuticals Major Business
- 2.4.3 Apellis Pharmaceuticals Drugs for PNH Product and Services
- 2.4.4 Apellis Pharmaceuticals Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Apellis Pharmaceuticals Recent Developments/Updates
- 2.5 Amgen
- 2.5.1 Amgen Details
- 2.5.2 Amgen Major Business
- 2.5.3 Amgen Drugs for PNH Product and Services
- 2.5.4 Amgen Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Amgen Recent Developments/Updates
- 2.6 Samsung Bioepis
- 2.6.1 Samsung Bioepis Details
- 2.6.2 Samsung Bioepis Major Business
- 2.6.3 Samsung Bioepis Drugs for PNH Product and Services
- 2.6.4 Samsung Bioepis Drugs for PNH Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Samsung Bioepis Recent Developments/Updates
3 Competitive Environment: Drugs for PNH by Manufacturer
- 3.1 Global Drugs for PNH Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Drugs for PNH Revenue by Manufacturer (2021-2026)
- 3.3 Global Drugs for PNH Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Drugs for PNH by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Drugs for PNH Manufacturer Market Share in 2025
- 3.4.3 Top 6 Drugs for PNH Manufacturer Market Share in 2025
- 3.5 Drugs for PNH Market: Overall Company Footprint Analysis
- 3.5.1 Drugs for PNH Market: Region Footprint
- 3.5.2 Drugs for PNH Market: Company Product Type Footprint
- 3.5.3 Drugs for PNH Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Drugs for PNH Market Size by Region
- 4.1.1 Global Drugs for PNH Sales Quantity by Region (2021-2032)
- 4.1.2 Global Drugs for PNH Consumption Value by Region (2021-2032)
- 4.1.3 Global Drugs for PNH Average Price by Region (2021-2032)
- 4.2 North America Drugs for PNH Consumption Value (2021-2032)
- 4.3 Europe Drugs for PNH Consumption Value (2021-2032)
- 4.4 Asia-Pacific Drugs for PNH Consumption Value (2021-2032)
- 4.5 South America Drugs for PNH Consumption Value (2021-2032)
- 4.6 Middle East & Africa Drugs for PNH Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Drugs for PNH Sales Quantity by Type (2021-2032)
- 5.2 Global Drugs for PNH Consumption Value by Type (2021-2032)
- 5.3 Global Drugs for PNH Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Drugs for PNH Sales Quantity by Application (2021-2032)
- 6.2 Global Drugs for PNH Consumption Value by Application (2021-2032)
- 6.3 Global Drugs for PNH Average Price by Application (2021-2032)
7 North America
- 7.1 North America Drugs for PNH Sales Quantity by Type (2021-2032)
- 7.2 North America Drugs for PNH Sales Quantity by Application (2021-2032)
- 7.3 North America Drugs for PNH Market Size by Country
- 7.3.1 North America Drugs for PNH Sales Quantity by Country (2021-2032)
- 7.3.2 North America Drugs for PNH Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Drugs for PNH Sales Quantity by Type (2021-2032)
- 8.2 Europe Drugs for PNH Sales Quantity by Application (2021-2032)
- 8.3 Europe Drugs for PNH Market Size by Country
- 8.3.1 Europe Drugs for PNH Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Drugs for PNH Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drugs for PNH Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Drugs for PNH Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Drugs for PNH Market Size by Region
- 9.3.1 Asia-Pacific Drugs for PNH Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Drugs for PNH Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Drugs for PNH Sales Quantity by Type (2021-2032)
- 10.2 South America Drugs for PNH Sales Quantity by Application (2021-2032)
- 10.3 South America Drugs for PNH Market Size by Country
- 10.3.1 South America Drugs for PNH Sales Quantity by Country (2021-2032)
- 10.3.2 South America Drugs for PNH Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drugs for PNH Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Drugs for PNH Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Drugs for PNH Market Size by Country
- 11.3.1 Middle East & Africa Drugs for PNH Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Drugs for PNH Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Drugs for PNH Market Drivers
- 12.2 Drugs for PNH Market Restraints
- 12.3 Drugs for PNH Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Drugs for PNH and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Drugs for PNH
- 13.3 Drugs for PNH Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Drugs for PNH Typical Distributors
- 14.3 Drugs for PNH Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Drugs for PNH. Industry analysis & Market Report on Drugs for PNH is a syndicated market report, published as Global Drugs for PNH Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Drugs for PNH market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
